De Motu Cordis reports progress on the development of its dry powder inhaler (DPI) containing epinephrine (adrenaline) for inhaled anaphylaxis treatment.
News & Media
Latest news
De Motu Cordis reports progress on the development of its dry powder inhaler (DPI) containing epinephrine (adrenaline) for inhaled anaphylaxis treatment
De Motu Cordis News
Professor John Fraser and his team have been working on the Living Heart Project for over five years in developing a technology to keep hearts viable for longer, giving a much needed boost to heart transplant recipients.
Congratulations to our Company Founder, Professor John Fraser, who on Friday November 18, 2022, was the recipient of the Life Sciences Queensland (LSQ) McCullough Robertson Industry Excellence Award.
The Brisbane Economic Development Agency MedTech Global Accelerator Program is an exciting opportunity for DMC to further advance our commercial strategy and successfully position ourselves within the Medtech space.
On 1st March 2022, DMC Board, Management Committee and Leadership team and partners gathered, post Board Meeting, for dinner for the first-time post-pandemic.
This week our Company Founder Professor John Fraser presented to ICU intensivists and clinicians at Cleveland Clinic in Abu Dhabi. He outlined the latest thinking in ICU care and described concepts on the ICU room of the future, specifically designed to shorten required ICU care and improving patient outcomes.
De Motu Cordis features on Life Sciences Queensland Podcast Wednesday 27 October, 2021 Recently De Motu Cordis (DMC) was featured on the Life Sciences Queensland Podcast (Episode 12). Have a
DMC welcomes Board to new premises Tuesday 9 February, 2021 In February 2021, our DMC Board and Leadership Team met for the first time within our new office premises. Our
DMC Confirms $2,500,000 Investment from Queensland BDF Friday 22 May, 2020 Brisbane based De Motu Cordis Pty Ltd (DMC) is delighted to confirm receipt of a $2,500,000 investment from Queensland
DMC attends second session of the FAST Queensland program in San Francisco Sunday 26 January, 2020 DMC were excited to attend the second session of the FAST Queensland program in
Nothing is Impossible – Prof John Fraser on his DMC Journey Saturday 10 August, 2019 As a medical disruptor and the founder of Australia’s largest clinical multi-disciplinary research group, Professor
To stay up to date with DMC, follow us on LinkedIn.